Digital Pathology Market Size, Growth, Share & Trends Analysis

Based on product, the hardware accounts for the largest share of the digital pathology market, which is mainly attributable to its importance in facilitating the digitalization of pathology. The digital pathology market consists of various hardware categories, where whole-slide imaging (WSI) scanners represent essential components that form the basis of the technology through the transformation of conventional glass slides into electronic images, which can then be reviewed, studied, saved, and shared. The rising popularity of digital pathology within hospitals, labs, universities, and research facilities has resulted in a greater need for more sophisticated scanning machines.

Based on the type, the digital pathology market is segmented into human pathology and veterinary pathology. The human pathology segment accounted for the largest share owing to the increasing occurrence of cancers and other chronic diseases that require a correct diagnosis. The increasing demand for precision medicines, a high number of pathology tests performed, and increased adoption of digital pathology technology in hospitals, diagnostic laboratories, and medical facilities are some of the key factors fueling the growth of the segment. Digital pathology not only facilitates faster slide reviews but also enhances diagnosis accuracy through consultations and cooperation between specialists. Moreover, the growing use of AI-based image analysis, increased healthcare investments in digitization, and the growing use of digital pathology in diagnosing diseases and devising treatment plans are some other reasons behind the dominance of the segment in the market.

Based on the therapeutic area, the digital pathology market may be divided into oncology, hematology, gastroenterology, infectious diseases, neurology, and other therapeutic areas. Of all these segments, the oncology segment is the one that accounts for the highest market share in the digital pathology market, and is the most important application segment for digital pathology technologies. This is chiefly due to the increasing incidence of cancer in different parts of the world and the growing need for rapid and accurate diagnostics of disease. The need for more personalized and accurate treatment of cancers is another factor that increases the usage of digital pathology in the oncology segment.

Based on technology, the digital pathology market is segmented into conventional digital pathology and AI-enabled digital pathology. In 2025, conventional digital pathology holds a significant share of the digital pathology market, driven by high adoption rates of WSI scanners, digital workflow management, and image management software in various healthcare facilities such as hospitals, diagnostic centers, and other research institutes. Most healthcare providers continue to emphasize digitization of their pathology departments through the conversion of existing microscopy techniques to digital slides that can be scanned, stored, viewed, and shared remotely. Increasing usage of WSI systems, increased telepathology requirements, growing numbers of pathology cases, and the necessity of operational efficiency further reinforce this trend.

Based on application, the digital pathology market is segmented into clinical diagnostics, pre-clinical research, clinical trials, telepathology, academic & translational research, education & training, and others. The clinical diagnostics segment is expected to hold for the significant share of the market in 2025, owing to the growing use of digital pathology for everyday disease diagnosis and cancer screening and for improving pathology procedures. Increasing caseloads at hospitals and labs, rising incidences of cancers, increasing need for efficient and faster diagnosis processes, and growing approvals of digital pathology systems are driving their use. In addition to these factors, the introduction of artificial intelligence, whole slide imaging technology, and image analysis techniques in clinical processes has increased diagnostic efficiency and enabled precision medicine programs.

Based on end users, the digital pathology market can be classified as hospitals & health systems, diagnostic & reference laboratories, veterinary laboratories, pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes, and others. The share of hospitals & health systems is expected to grow significantly during 2025 because of the extensive adoption of digital pathology products in making primary diagnoses, increasing workload, higher cancer cases, and investments made in digital transformation within the healthcare sector. Digital pathology solutions, including WSI scanners, imaging software, AI-enabled diagnostics, and telepathology, are being adopted by hospitals to boost operational productivity and provide accurate diagnoses. Moreover, the approvals secured by digital pathology solutions, the need for remote consultation, and advancements in precision.